Lv1
50 积分 2025-06-03 加入
TP53 mutation predicts resistance to immune checkpoint inhibitor-based therapy in intrahepatic cholangiocarcinoma
2个月前
已完结
Neutrophil membrane-coated nanoparticles for targeted delivery of toll-like receptor 4 siRNA ameliorate LPS-induced acute lung injury
3个月前
已完结
Discovery of orally bioavailable phenyltetrazolium derivatives for the acute treatment and the secondary prevention of ischemic stroke
3个月前
已完结
GSPT1 degraders: research progress, development strategies and challenges
4个月前
已完结
Engineering a potent and long-acting GLP-1/Y2 receptor dual agonist as a multi-agonist therapy for diabetes and obesity
7个月前
已完结
Autism spectrum disorder
7个月前
已完结
Navigating the complexities of drug development for inflammatory bowel disease
7个月前
已完结
Discovery of a potent inhibitor targeting the cap-binding domain of the PB2 subunit of influenza RNA-dependent RNA polymerase
7个月前
已完结
Discovery of DFV890, a Potent Sulfonimidamide-Containing NLRP3 Inflammasome Inhibitor
8个月前
已完结
Blocking common γ chain cytokine signaling ameliorates T cell–mediated pathogenesis in disease models
8个月前
已完结
皖公网安备34019202002308
